Glial Fibrillary Acidic Protein Predicts Short-term Progression Independent of Relapse Activity in Primary Progressive Multiple Sclerosis

被引：0

作者：

Abdelhak, Ahmed ^{[1
,2
]}

Antweiler, Kai ^{[3
]}

Kowarik, Markus ^{[4
,5
]}

Senel, Makbule ^{[2
]}

Havla, Joachim ^{[6
]}

Zettl, Uwe K. ^{[7
]}

Kleiter, Ingo ^{[8
]}

Skripuletz, Thomas ^{[9
]}

Haarmann, Axel ^{[10
]}

Stahmann, Alexander ^{[11
]}

Huss, Andre ^{[2
]}

Gingele, Stefan ^{[9
]}

Krumbholz, Markus ^{[4
,5
,12
,13
]}

Kuhle, Jens ^{[14
,15
]}

Benkert, Pascal ^{[14
,15
]}

Friede, Tim ^{[3
]}

Ludolph, Albert C. ^{[2
]}

Ziemann, Ulf ^{[4
,5
]}

Kuempfel, Tania ^{[6
]}

Tumani, Hayrettin ^{[2
]}

机构：

[1] Univ Calif San Francisco UCSF, Dept Neurol, San Francisco, CA USA

[2] Univ Hosp Ulm, Dept Neurol, Ulm, Germany

[3] Univ Med Ctr Goettingen, Dept Med Stat, Gottingen, Germany

[4] Univ Tubingen Hosp, Dept Neurol & Stroke, Tubingen, Germany

[5] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany

[6] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, LMU Hosp, Munich, Germany

[7] Univ Rostock, Neuroimmunol Sect, Dept Neurol, Rostock, Germany

[8] Behandlungszentrum Kempfenhausen Multiple Skleros, Marianne Strauss Klin, Berg, Germany

[9] Hannover Med Sch, Dept Neurol, Hanover, NH USA

[10] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany

[11] Forsch & Projektentwicklungs gGmbH, MS Registry German MS Soc, Hanover, NH USA

[12] Univ Hosp Brandenburg, Brandenburg Med Sch Theodor Fontane, Dept Neurol & Pain Treatment, MS Ctr,Ctr Translat Med,Immanuel Klin Rudersdorf, Rudersdorf, Germany

[13] Brandenburg Med Sch Theodor Fontane, Fac Hlth Sci Brandenburg, Rudersdorf, Germany

[14] Univ Hosp Basel, Dept Clin Res, Basel, Switzerland

[15] Univ Hosp Basel, Dept Neurol, Basel, Switzerland

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P632/1843

引用

页码：554 / 556

页数：3

共 50 条

[1] Association of serum glial fibrillary acidic protein with progression independent of relapse activity in multiple sclerosis
Rosenstein, Igal
Nordin, Anna
Sabir, Hemin
Malmestrom, Clas
Blennow, Kaj
Axelsson, Markus
Novakova, Lenka
JOURNAL OF NEUROLOGY, 2024, 271 (07) : 4412 - 4422
[2] Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis
Abdelhak, Ahmed
Antweiler, Kai
Kowarik, Markus C.
Senel, Makbule
Havla, Joachim
Zettl, Uwe K.
Kleiter, Ingo
Skripuletz, Thomas
Haarmann, Axel
Stahmann, Alexander
Huss, Andre
Gingele, Stefan
Krumbholz, Markus
Benkert, Pascal
Kuhle, Jens
Friede, Tim
Ludolph, Albert C.
Ziemann, Ulf
Kuempfel, Tania
Tumani, Hayrettin
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (02): : 477 - 485
[3] Serum glial fibrillary acidic protein predicts disease progression in multiple sclerosis
Madill, Evan
Healy, Brian C.
Molazadeh, Negar
Polgar-Turcsanyi, Mariann
Glanz, Bonnie I.
Weiner, Howard L.
Chitnis, Tanuja
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (10): : 2719 - 2730
[4] Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation
Jiang, Xiaotong
Shen, Changyu
Teunissen, Charlotte E.
Wessels, Mark
Zetterberg, Henrik
Giovannoni, Gavin
Singh, Carol M.
Caba, Bastien
Elliott, Colm
Fisher, Elizabeth
de Moor, Carl
Belachew, Shibeshih
Gafson, Arie R.
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 (09) : 1070 - 1079
[5] Glial fibrillary acidic protein and multiple sclerosis progression independent of acute inflammation
Jiang, X.
Gafson, A. R.
Shen, C.
Singh, C. M.
Caba, B.
Fisher, E.
de Moor, C.
Belachew, S.
MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 821 - 821
[6] Baseline serum glial fibrillary acidic protein levels associate with progression independent of relapse activity in relapsing-remitting multiple sclerosis
Rosenstein, Igal
Axelsson, Markus
Malmestrom, Clas
Sandgren, Sofia
Lycke, Jan
Novakova, Lenka
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 575 - 576
[7] Stool glial fibrillary acidic protein is a biomarker of progressive multiple sclerosis and predicts disease worsening
Schwerdtfeger, Luke
Montini, Federico
Ekwudo, Millicent
LeServe, Danielle
Glanz, Bonnie
Chitnis, Tanuja
Cox, Laura
Weiner, Howard
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 577 - 577
[8] Serum glial fibrillary acidic protein (sGFAP) levels are reduced by fingolimod treatment and prognosticate disease progression independent of relapse activity in multiple sclerosis
Maceski, Aleksandra Maleska
Benkert, Pascal
Oechtering, Johanna
Schadelin, Sabine
Zadic, Amar
Gomez, Juan Francisco Vilchez
Melie-Garcia, Lester
Cagol, Alessandro
Galbusera, Riccardo
Subramaniam, Suvitha
Lorscheider, Johannes
Fischer-Barnicol, Bettina
Achtnichts, Lutz
Findling, Oliver
Lalive, Patrice
Uginet, Marjolaine
Mueller, Stefanie
Pot, Caroline
Mathias, Amandine
Du Pasquier, Renaud
Hoepner, Robert
Chan, Andrew
Disanto, Giulio
Zecca, Chiara
Conen, David
Buser, Andreas
DSouza, Marcus
Yaldizli, Ozgur
Derfuss, Tobias
Gobbi, Claudio
Khalil, Michael
Brassat, David
Janiaud, Perrine Marine Charlotte
Hemkens, Lars
Oksenberg, Jorge R.
Wiendl, Heinz
Berger, Klaus
Hermesdorf, Marco
Piehl, Fredrik
Kappos, Ludwig
Abdelhak, Ahmed
Granziera, Cristina
Willemse, Eline
Leppert, David
Kuhle, Jens
MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 56 - 58
[9] Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
Axelsson, M.
Malmestrom, C.
Nilsson, S.
Haghighi, S.
Rosengren, L.
Lycke, J.
JOURNAL OF NEUROLOGY, 2011, 258 (05) : 882 - 888
[10] Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis
M. Axelsson
C. Malmeström
S. Nilsson
S. Haghighi
L. Rosengren
J. Lycke
Journal of Neurology, 2011, 258 : 882 - 888

← 1 2 3 4 5 →